Literature DB >> 15625379

Unusual cases in multiple myeloma and a dramatic response in metastatic lung cancer: case 4. Mutation of the epidermal growth factor receptor in an elderly man with advanced, gefitinib-responsive, non-small-cell lung cancer.

Daniel Cho1, Olivier Kocher, Jeffrey C Lee, Daniel G Tenen, Matthew L Meyerson, Pasi A Janne, Balazs Halmos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15625379     DOI： 10.1200/JCO.2005.07.169

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  2 in total

1.  Epidermal growth factor receptor (EGFR) mutations in a series of non-small-cell lung cancer (NSCLC) patients and response rate to EGFR-specific tyrosine kinase inhibitors (TKIs).

Authors:  E M Martínez-Navarro; J Rebollo; R González-Manzano; M Sureda; E Evgenyeva; B Valenzuela; F J Fernández; J Forteza; A Brugarolas
Journal:  Clin Transl Oncol       Date:  2011-11       Impact factor: 3.405

2.  The impact of rescue or maintenance therapy with EGFR TKIs for Stage IIIb-IV non-squamous non-small-cell lung cancer patients requiring mechanical ventilation.

Authors:  Te-Chun Hsia; Chih-Yen Tu; Hung-Jen Chen
Journal:  BMC Anesthesiol       Date:  2014-07-16       Impact factor: 2.217
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.